AI assistant
Sending…
Sana Biotechnology, Inc. — Director's Dealing 2021
Sep 14, 2021
32303_dirs_2021-09-14_0756b9d2-d358-468e-92c1-8ea5d1e7d7bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-09-10
Reporting Person: Hordo Christian (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-10 | Common Stock | S | 1477.00 | $25.00 | Disposed | 942455.00 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
More from Sana Biotechnology, Inc.
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
May 15
Share Issue/Capital Change
2026
May 11
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Board/Management Information
2026
Apr 24
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 4
Capital/Financing Update
2026
Mar 3